预测小分子的氧酶增殖器激活受体马强度:由Enalos云平台支持的协同共识模型和深度学习结合亲和关系方法
Maria Antoniou1,2,3, Konstantinos D Papavasileiou3,4, Antreas Tsoumanis1,3,4
1Department of ChemoInformatics, NovaMechanics Ltd, 1070, Nicosia, Cyprus.
Molecular diversity
|June 14, 2025
概括
这项研究开发了先进的计算模型来预测Peroxisome增殖器激活受体玛 (PPARγ) 抗剂的活性. 这些工具通过有效选潜在化合物,有助于发现新的抗糖尿病药物.
科学领域:
- 计算化学是一种计算化学.
- 药理学 药理学是指药理学的学科.
- 药物发现 药物发现
背景情况:
- 氧酶增殖器激活受体玛 (PPARγ) 抗剂对于调节葡萄糖和脂质代谢至关重要.
- PPARγ调节器是治疗糖尿病的有希望的治疗候选者.
- 需要有效的方法来识别新型PPARγ抗剂.
研究的目的:
- 开发和验证先进的in silico模型来预测PPARγ抗剂的结合亲和力和生物活性.
- 提供针对PPARγ的小分子有效虚拟选的工具.
- 为了获得对PPARγ活动调节的机制性见解.
主要方法:
- 开发一种神经网络模型,根据分子对接得分来对化合物结合亲和力进行分类.
- 实施共识模型 (随机森林,支持矢量机,k-最近邻居) 来预测对抗性活动.
- 根据经合组织指导方针严格验证模型,包括对少数群体类检测的评估.
主要成果:
- 成功开发和验证了两个in silico模型,用于预测PPARγ抗剂的特性.
- 通过一项案例研究选和多基基物质 (PFAS) 证明了模型的实际应用.
- 获得了对分子描述因子对PPARγ活性影响的机制性见解.
结论:
- 开发的计算模型提供了有效和可访问的虚拟选功能,用于识别PPARγ调节器.
- 这些工具支持新型抗糖尿病药物的发现.
- 这些模型被集成到用户友好的Web应用程序中,以实现更广泛的可访问性.
相关概念视频
Ligand Binding Sites
12.8K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
12.8K
The Equilibrium Binding Constant and Binding Strength
12.8K
The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
12.8K
Conserved Binding Sites
4.2K
Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
4.2K
The Two-State Receptor Model
1.9K
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with...
The binding affinity of a drug determines its interaction with...
1.9K
Protein-protein Interfaces
12.5K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
12.5K
Drug-Receptor Interactions
5.1K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
5.1K


